CDEK
← All organizations

Dow Pharmaceutical Sciences

For profitContributed to NMEWebsite ↗

Also known as: Dow Hickam Pharmaceuticals | DOW PHARM

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2006

First marketed drug

Apr 19, 1954

First NDA

Jun 6, 2014

Last known activity

Aug 11, 2015

Acquired by Bausch Health Companies on Dec 11, 2008

Timeline

1890s

  1. Jan 1, 1897

    Dow Pharmaceutical Sciences— Founded

1950s

  1. Apr 19, 1954

    bacitracin— Marketing Organization

1960s

  1. Jan 1, 1960

    Pitman-Moore— Acquired

  2. Feb 3, 1969

    piperacetazine— NDA Secondary Org

2000s

  1. Jun 1, 2001

    Solano Clinical Research— Acquired

  2. Jan 1, 2008

    Rohm & Haas— Acquired

  3. Dec 11, 2008

    Bausch Health Companies— Acquired By

2010s

  1. Jun 6, 2014

    efinaconazole— NDA Organization

Drugs by trial phase (10 distinct, 17 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (14)

Subsidiaries (3 direct, 4 total across the full acquisition tree)

Recent trials (16)

Details

Founded
Petaluma, CA, US Jan 1, 1897
First NDA
Jun 6, 2014
Last known activity
Aug 11, 2015